The Indian subsidiary of UK pharma major AstraZeneca has announced a Central Drugs Standard Control Organization (CDSCO) approval to import for sale and distribution of trastuzumab deruxtecan ...

Boston, USA-based biotech Aera Therapeutics, which is harnessing next-generation enabling delivery technologies and precision ...

Denmark, oncology-based Pharmacosmos today announced that it has assumed the worldwide rights, excluding select Asia-Pacific ...

US President Donald Trump sent shivers through the pharmaceutical industry as he vowed to dramatically reduce the high drug prices that have long been a feature of the US market.

US pharma major Eli Lilly (NYSE: LLY) announced a significant expansion of its long-standing alliance with Purdue University, ...

Shine Technologies, a private nuclear fusion corporation based in Wisconsin, USA, has entered into a definitive agreement to ...

N) today presented data from the Phase III REAL8 basket study, which showed that once-weekly Sogroya (somapacitan) was ...

Sylentis, a wholly-owned subsidiary of Spanish drugmaker PharmaMar (MSE: PHM), announced top-line results from the SYL1801-II ...

A sustainable healthcare system requires holistic approaches. However, the counterproposal to the cost-control initiative, which was rejected by the people, demonstrates once again that the Swiss ...

UK-based pharma major AstraZeneca (LSE: AZN) has started construction on a new manufacturing site for small molecule drugs in ...

The UK’s BioIndustry Association (BIA) has publishes its 10-year Vision for the UK life science sector called “A Vision for ...

New figures from European industry group EFPIA paint a stark picture of the growing divide in access to innovative medicines ...